| David Wang
Engineering A Cure for Diabetes
| Division: | Biotechnologie | | Catégorie: | Sénior | | Région: | London District | | Ville: | London, ON | | École: | A.B. Lucas S.S. | | Sommaire: | This project investigated the feasibility of the cost-effective production of a human regulatory cytokine, IL-13 in transgenic plants for the treatment of Type 1 diabetes (T1D). Transgenic plants producing large amounts of IL-13 were generated. In vitro bioassays demonstrated that the plant-derived IL-13 effectively induced the proliferation of T1D-associated T-lymphocytes. Thus, this study represents a novel, low-cost, oral, immune-based therapy for diabetes. |
| Prix | Valeur | Mention honorable - Biotechnologie et les sciences pharmaceutiques
Sénior
Sponsor: Fondation pour la recherche en santé de Rx&D | 100,00 $ | | Total | 100,00 $ | |
Imprimer/Télécharger en format PDF